Drug action hypothesis: how membrane expansion, calmodulin inhibition, and sickle cell therapy relate.
D000755:Anemia, Sickle Cell / Q000097:blood / Q000188:drug therapy*; D000779:Anesthetics, Local / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002135:Calcium-Binding Proteins / Q000378:metabolism*; D002147:Calmodulin / Q000037:antagonists & inhibitors / Q000378:metabolism*; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000502:physiology*; D004912:Erythrocytes / Q000502:physiology*; D006801:Humans; D008954:Models, Biological; D010640:Phenothiazines; D015032:Zinc / Q000627:therapeutic use
D000779:Anesthetics, Local; D014150:Antipsychotic Agents; D002135:Calcium-Binding Proteins; D002147:Calmodulin; D010640:Phenothiazines; D015032:Zinc